Kerry D. Ingalls

Chief Operating Officer, Poseida Therapeutics, Inc.

Companies

Poseida Therapeutics, Inc.Chief operating officer Jul 9, 2020 to Mar 18, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Poseida Therapeutics, Inc.55,000 shares²Mar 16, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 16, 2022Bought 3,000 shares at $3.98 of Poseida Therapeutics, Inc.²
Mar 1, 2022Granted 50,000 shares of Poseida Therapeutics, Inc.³
Nov 17, 2021Bought 2,000 shares at $7.00 of Poseida Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPoseida Therapeutics, Inc., Chief operating officer
2
SEC EDGARPoseida Therapeutics, Inc. shares after the filing of Mar 16, 2022
3
SEC EDGARForm 4 filed Mar 1, 2022
4
SEC EDGARForm 4 filed Nov 18, 2021